204 related articles for article (PubMed ID: 33050910)
1. Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases.
Guénolé M; Lucia F; Bourbonne V; Dissaux G; Reygagne E; Goasduff G; Pradier O; Schick U
BMC Cancer; 2020 Oct; 20(1):991. PubMed ID: 33050910
[TBL] [Abstract][Full Text] [Related]
2. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
3. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
[TBL] [Abstract][Full Text] [Related]
4. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
6. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
Kroeze SGC; Fritz C; Schaule J; Siva S; Kahl KH; Sundahl N; Blanck O; Kaul D; Adebahr S; Verhoeff JJC; Skazikis G; Roeder F; Geier M; Eckert F; Guckenberger M
BJU Int; 2021 Jun; 127(6):703-711. PubMed ID: 33113260
[TBL] [Abstract][Full Text] [Related]
8. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases.
Kowalski ES; Remick JS; Sun K; Alexander GS; Khairnar R; Morse E; Cherng HR; Berg LJ; Poirier Y; Lamichhane N; Becker S; Chen S; Molitoris JK; Kwok Y; Regine WF; Mishra MV
Radiat Oncol; 2020 Oct; 15(1):245. PubMed ID: 33109224
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO.
Scoccianti S; Olmetto E; Pinzi V; Osti MF; Di Franco R; Caini S; Anselmo P; Matteucci P; Franceschini D; Mantovani C; Beltramo G; Pasqualetti F; Bruni A; Tini P; Giudice E; Ciammella P; Merlotti A; Pedretti S; Trignani M; Krengli M; Giaj-Levra N; Desideri I; Pecchioli G; Muto P; Maranzano E; Fariselli L; Navarria P; Ricardi U; Scotti V; Livi L
Neuro Oncol; 2021 Oct; 23(10):1750-1764. PubMed ID: 34050669
[TBL] [Abstract][Full Text] [Related]
11. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
[TBL] [Abstract][Full Text] [Related]
12. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
[TBL] [Abstract][Full Text] [Related]
13. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of stereotactic radiotherapy for metastases from renal cell carcinoma.
Majewski W; Tabor M; Banaszek P; Glowacki G; Rokicki W; Tukiendorf A
Neoplasma; 2016; 63(1):99-106. PubMed ID: 26639239
[TBL] [Abstract][Full Text] [Related]
15. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
17. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
18. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
Calderon B; Vazquez L; Belkacemi M; Pourel N
Eur J Med Res; 2023 Jul; 28(1):233. PubMed ID: 37443046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
